CEL-SCI Aktie
WKN DE: A2DY0D / ISIN: US1508376076
28.08.2025 04:54:28
|
CEL-SCI Corp. Prices Public Offering Of 1.11 Mln Shares At $9.00/shr
(RTTNews) - CEL-SCI Corp. (CVM), a clinical stage cancer immunotherapy company, announced the pricing of a public offering of about 1.11 million shares of its common stock at $9.00 per share.
Total gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $10 million.
The offering is expected to close on August 29, 2025.
The company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CEL-SCI Corp (New) Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |